LINEZOLID GXP linezolid 600 mg tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

linezolid, Quantity: 600 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Linezolid

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: povidone; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; sodium dihydrogen citrate; titanium dioxide; hypromellose; PEG-40 stearate

Ievadīšanas:

Oral

Vienības iepakojumā:

30, 10

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Produktu pārskats:

Visual Identification: Off-white, oblong, biconvex, film-coated tablet.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2016-01-28